Table 2 PFS-rates
From: Linac-based stereotactic radiotherapy and radiosurgery in patients with meningioma
PFS-rates | |||
|---|---|---|---|
3 years | 5 years | 10 years | |
Entire cohort | 92.30% | 87.00% | 84.10% |
Group 1 (unknown/Grade I) | 96.80% | 92.70% | 89.60% |
Group 2 (Grade II/III) | 52.60% | 19.70% | n/a |
Unknown histology | 97.40% | 94.20% | 90.40% |
Grade I | 93.90% | 85.80% | 85.80% |
Grade II | 62.70% | 41.80% | n/a |
Grade II | 29.30% | n/a | n/a |
Volume < 60 ccm | 95.80% | 91.20% | 89.30% |
Volume > 60 ccm | 100% | 85.70% | n/a |
Primary RT | 98.10% | 98.10% | 96.80% |
Postoperative RT | 87.60% | 78.10% | 73.40% |
nFSRT | 92.70% | 88.90% | 86.90% |
hFSRT | 92.40% | 80.90% | n/a |
SRS | 95.80% | 87.80% | n/a |